Sunday 18 October 2026
Export BYSI’s income statement to Excel — free account
BeyondSpring Inc.
BYSI Healthcare Biotechnology
In the quarter to June 2026, EPS grew 50.0% and free cash flow grew 35.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
0.56
0.02
−3.45%
Follow BYSI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
0.98 | 0.93 | 0.64 | 0.46 | |
Current Ratio |
1.89 | 1.54 | 1.09 | 0.70 | |
Net Debt/EBITDA |
7.39 | 4.56 | 3.55 | 3.81 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.72 | 2.58 | 1.52 | 4.44 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.10) | (0.14) | (0.08) | (0.09) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.10) | (0.14) | (0.08) | (0.09) | |
Cash per Share |
0.31 | 0.31 | 0.19 | 0.16 | |
Shareholders Equity per Share |
(0.49) | (0.59) | (0.74) | (0.88) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.49) | (0.59) | (0.74) | (0.88) | |
Free Cash Flow |
(4.19) | (5.50) | (3.28) | (3.77) | |
Working Capital |
11.52 | 7.31 | 1.13 | (4.29) | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
(24.88) | (29.04) | (35.26) | (40.73) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
1.21 | 0.33 | 0.50 | 0.53 | |
Average Assets |
25.19 | 30.12 | 27.76 | 22.82 | |
Average Common Equity |
(29.18) | (19.14) | (21.51) | (26.78) |
Columns are period end dates